EFFECT OF SACUBITRIL/VALSARTAN VS. ENALAPRIL ON CHANGES IN BACKGROUND MEDICAL THERAPY OVER TIME IN THE PARADIGM-HF TRIAL

被引：0
|
作者：
Bhatt, Ankeet [1 ]
Vaduganathan, Muthiah [1 ]
Claggett, Brian [1 ]
Liu, Jiankang [1 ]
Packer, Milton [1 ]
Desai, Akshay S. [1 ]
Lefkowitz, Martin [1 ]
Rouleau, Jean L. [1 ]
Shi, Victor [1 ]
Zile, Michael [1 ]
Swedberg, Karl [1 ]
Vardeny, Orly [1 ]
McMurray, John [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415-117
引用
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [41] Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial
    O'Meara, Eileen
    Prescott, Margaret F.
    Rouleau, Jean L.
    Chiang, Lu-May
    Solomon, Scott D.
    Swedberg, Karl
    Packer, Milton
    McMurray, John J. V.
    Zile, Michael R.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S29 - S30
  • [42] Clinical Implication of Very Low Dose of Sacubitril/valsartan for Patients With Heart Failure With Reduced Ejection Fraction; Beyond PARADIGM-HF and PIONEER-HF Trial
    Kim, Hyoeun
    Oh, Jaewon
    Ha, Jaehyung
    Chun, Kyeong-Hyeon
    Lee, Chan Joo
    Park, Sungha
    Lee, Sang-Hak
    Kang, Seok-Min
    CIRCULATION, 2019, 140
  • [43] Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
    Jain, Anil Ranjeetmal
    Aggarwal, Rakesh Kumar
    Rao, Nanyam Srinivas
    Billa, Gauri
    Kumar, Shankar
    INDIAN HEART JOURNAL, 2020, 72 (06) : 535 - 540
  • [44] Better health-related quality of life in patients treated with sacubitril/valsartan compared with enalapril, irrespective of NYHA class: Analysis of EQ-5D in PARADIGM-HF
    Trueman, D.
    Kapetanakis, V.
    Briggs, A.
    Lewis, E.
    Rouleau, J.
    Solomon, S. D.
    Swedberg, K.
    Zile, M. R.
    Packer, M.
    McMurray, J. J. V.
    Croft, D. C.
    Haroun, R.
    Gielen, V.
    EUROPEAN HEART JOURNAL, 2017, 38 : 698 - 698
  • [45] Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial
    Bouabdallaoui, Nadia
    Claggett, Brian
    Zile, Michael R.
    McMurray, John J. V.
    O'Meara, Eileen
    Packer, Milton
    Prescott, Margarett F.
    Swedberg, Karl
    Solomon, Scott D.
    Rouleau, Jean L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (12) : 1701 - 1709
  • [46] Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction
    Owens, Robert L.
    Birkeland, Kade
    Heywood, J. Thomas
    Steinhubl, Steven R.
    Dorn, Jonas
    Grant, Daniel
    Fombu, Emmanuel
    Khandwalla, Raj
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (12) : 1466 - 1471
  • [47] Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
    Desai, Akshay S.
    Solomon, Scott D.
    Shah, Amil M.
    Claggett, Brian L.
    Fang, James C.
    Izzo, Joseph
    McCague, Kevin
    Abbas, Cheryl A.
    Rocha, Ricardo
    Mitchell, Gary F.
    Izzo, Joseph
    Martinez-Castrillon, Melvin
    Beato, Jorge
    Shah, Vipul
    Pianko, Leonard
    Bouza, Manuel
    Alhaddad, Mohsin
    Kashani, Amir
    Sampognaro, Gregory
    Stahl, Lloyd
    Lehman, John
    Lebhar, Steve
    Napoli, Mark
    Consuegra, Aurelio Torres
    Gonzalez, Humberto
    Lloret, Ramon
    Ariani, Mehrdad
    Azizad, Masoud
    Shah, Anil
    Henderson, David
    Covalesky, John
    Brabham, David
    Chane, Majed
    Sanchez, Eulogio
    Vega, Ramses
    Clay, Anthony
    McClure, John
    Sogade, Felix
    Ortiz-Munoz, Luis
    Lewis, Todd
    Zequeira, Argentina Gonzalez
    Shah, Rakesh
    Lepor, Norman
    Gonzalez, Marisela
    Tidman, Raymond
    Berman, Jeffrey
    Lorenz, David
    Nanna, Michele
    Greene, Trevor
    Portnay, Edward
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1077 - 1084
  • [48] Effects of sacubitril/valsartan vs. enalapril in paediatric patients with heart failure due to systemic LV systolic dysfunction: Design and rationale of the PANORAMA-HF study
    Shaddy, R.
    Chen, F.
    Canter, C.
    Halnon, N.
    Rossano, J.
    Kantor, P.
    Bonnet, D.
    Burch, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 411 - 411
  • [49] Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial
    Butt, Jawad H.
    Ibrahim, Wasyla
    Dewan, Pooja
    Desai, Akshay S.
    Kober, Lars
    Prescott, Margaret F.
    Lefkowitz, Martin P.
    Rouleau, Jean L.
    Solomon, Scott D.
    Zile, Michael R.
    Packer, Milton
    Jhund, Pardeep S.
    McMurray, John J. V.
    CIRCULATION-HEART FAILURE, 2023, 16 (03) : 247 - 258
  • [50] Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Thomas, Sabu
    Holwerda, N. J.
    Cohn, Jay N.
    CIRCULATION-HEART FAILURE, 2008, 1 (01) : 34 - 42
12345